Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
Year: 2013
Type: article
Source: Science Translational Medicine
Authors: Jason M. Uslaner, Spencer J. Tye, Donnie M. Eddins, Xiaohai Wang, Steven V. Fox, Alan T. Savitz, Jacquelyn Binns, Christopher E. Cannon, Susan L. Garson, Lihang Yao, Robert Hodgson, Joanne Stevens, Mark R. Bowlby, Pamela L. Tannenbaum, Joseph Brunner, Terrence P. Mcdonald, Anthony L. Gotter, Scott D. Kuduk, Paul J. Coleman, Christopher J. Winrow, John J. Renger
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2066700011
